The interest in drug discovery activities in the marine area has increased significantly during the past decades. The chance to identify attractive candidates for medical use in the marine environment, especially those with new modes of action, is significantly higher than in any other ecological system. This has lead to a boom in marine biotechnology and a strong demand for substances derived from marine organisms. For SeaLife the ocean with its enormous diversity is the ideal source for discovering novel anti-infective compounds.
The sea – high diversity with enormous potential
Most marine organisms lack classical immune systems and protect themselves solely by using chemical defense strategies.
Most marine organisms lack classical immune systems and protect themselves solely by using chemical defense strategies. These organisms offer a wide range of unexplored biologically active substances for further use in drug development. In that field, SeaLife Pharma has successfully established the company as a reliable partner for discovering & developing marine anti-infective substances. With the marine microbial platform and its cooperation partners (University of Düsseldorf; Haus des Meeres Vienna; Department of Marine Biology, University of Vienna, University of Athens), SeaLife Pharma is able to constantly identify attractive substances for further development.
